Laboratory management

FCGR2A polymorphism can predict which colorectal cancer patients may respond to cetuximab

Deubiquitinating enzyme USP14 may predict endometrial cancer recurrence

Theranos is currently fighting for its life - but its story may not be over yet…

We can argue about how many diagnostic errors happen each year, but we can’t deny that there are too many of them. And when one of those errors is ours, denial is especially inappropriate – but how many of us feel comfortable about a confessional with the patient? In the first installment of a two-part feature, we examine the difficulties around disclosure and communication of diagnostic errors.

Financial and personnel considerations for bringing mass spectrometry into the clinical laboratory

Laboratory professionals need to be involved in the total testing process to improve patient outcomes and avoid harm

Founder Elizabeth Holmes admits that direct-to-consumer testing company Theranos’ technology doesn’t work – and wasn’t often used

Researcher and entrepreneur explains how she hopes to help others take a great scientific idea to reality

Intelligent incorporation of automated technologies into pathology laboratories will improve service provision by complementing – not replacing – a highly skilled workforce

Molecular diagnostics are welcome reinforcements in the raging battle against institutional infection and antibiotic resistance